Jackie Hunter, CEO BenevolentBio is giving a talk at Web Summit 2017 on how Artificial Intelligence is revolutionising the methods in drug development.
Jerome Pesenti CEO, BenevolentTech spoke at Data Driven NYC on October 16th, 2017, about how BenevolentAI is using data to help scientists generate and validate hypotheses.
Jackie Hunter, CEO BenevolentBio shares her thoughts on how Artificial Intelligence is accelerating drug discovery
BenevolentBio CEO Jackie Hunter speaks about how artificial intelligence has application in health care.
Ken Mulvany, Founder, BenevolentAI, is interviewed by Hot Topics on BenevolentAI as a company and the challenge we are trying to solve. The interview includes how we are helping researchers to access and make sense of the enormous amount of data now available to them.
Jackie Hunter, CEO BenevolentBio gave an interview to Innovation Forum and participated to a panel on how start-up-industry collaborations can be successfully initiated and maintained to drive innovation.
Matt Gooderick looks at the potential for the use of artificial intelligence in the health sector, including initiatives by IBM Watson, BenevolentAI and Babylon.
Listen to Kenneth Mulvany, CEO BenevolentAI discussing AI in Medicine at BBC Business Live
Professor Jackie Hunter, CEO, BenevolentBio, gave evidence at The House of Lords Science and Technology Select Committee
Listen to our founder Ken Mulvany discussing BenevolentAI's work on artificial intelligence applied to drug discovery.
Jérôme Pesenti introduces BenevolentAI's work on applying artificial intelligence to improve scientific discoveries
BenevolentAI team explains why the use of DGX-1 will help them in their daily work
by the team at BenevolentAI